![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Transient Indirect Bilirubin Elevations Associated With ABT-450/r/Ombitasvir and Dasabuvir With Ribavirin
|
|
|
Reported by Jules Levin
54th Annual Interscience Conference on Anti microbial Agents and Chemotherapy, September 5-9, 2014, Washington, DC
Gregory T Everson1, Mark S Sulkowski2, Kosh Agarwal3, Bo Fu4, Tolga Baykal4, Eoin Coakley4, Barbara McGovern4, Stephen Shafran5
1University of Colorado Denver, Aurora, Colorado, United States; 2Johns Hopkins University, Balti more, Maryland, United States; 3Insti tute of Liver Studies, Kings College Hospital, London, United Kingdom; 4AbbVie Inc., North Chicago, Illinois, United States; 5University of Alberta, Edmonton, Alberta, Canada
![HCV1.gif](../images/090814/090814-15/HCV1.gif)
![HCV2.gif](../images/090814/090814-15/HCV2.gif)
![HCV3.gif](../images/090814/090814-15/HCV3.gif)
![HCV4.gif](../images/090814/090814-15/HCV4.gif)
![HCV5.gif](../images/090814/090814-15/HCV5.gif)
![HCV6.gif](../images/090814/090814-15/HCV6.gif)
![HCV7.gif](../images/090814/090814-15/HCV7.gif)
![HCV8.gif](../images/090814/090814-15/HCV8.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|